FDA Approved: PARICALCITOL — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for PARICALCITOL from Amneal Pharmaceuticals LLC. This action concerns the generic PARICALCITOL product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease On Dialysis
• Hyperparathyroidism in Chronic Kidney Disease

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

SUPPL AP for PARICALCITOL (PARICALCITOL)